A pathology report of AR 80% is usually indicative of a favorable tumor prognosis. Pathology report AR is an immunohistochemistry test that is often seen in tumor pathology, and its result is an antigen technical test data. AR represents an androgen receptor, and other immunohistochemical markers include Er, PR, Her-2, etc. AR is usually associated with ER and PR, and is usually expressed in conjunction with estrogen and progesterone receptors, which are usually expressed at a positive rate of 60%-70%. Overall, a positive AR is an indication of a better prognosis for the tumor. It is also indicative of the efficacy of treatment for endocrine diseases treated with megestrol; the higher the AR positivity rate, the more effective the treatment. The prognosis of a certain disease should not be judged because of the abnormality of one index, and it is recommended to cooperate with the doctor to improve other related examinations and actively treat the disease.